MINNEAPOLIS, May 03, 2025 (GLOBE NEWSWIRE) — Endogenex, a clinical-stage medical device company dedicated to improving outcomes in individuals with type 2 diabetes (T2D), presented significant results from its REGENT-1 Australia clinical study at…Read More

You might also be interested in reading Circle launches USDC stablecoin on Polkadot Asset Hub.